Company Filing History:
Years Active: 2004
Title: Dinah Parums: Innovator in Targeted Therapeutics
Introduction
Dinah Parums is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of targeted therapeutics, particularly in relation to diseases associated with scarring and fibrosis. Her innovative work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
Dinah holds one patent that focuses on an isolated target sequence. This target sequence is a splice variant of PDE5, referred to as PDE5 1, with a component presented as SEQ ID No 1. The identified target sequence can be utilized to identify agents, such as modulators, that are useful in the prevention and treatment of diseases related to scarring and fibrosis. Additionally, it can selectively identify smooth muscle cells, myofibroblasts, and myoepithelial cells in samples of both normal and diseased tissue.
Career Highlights
Dinah Parums is currently employed at Pfizer Corporation, where she continues to advance her research and development efforts. Her work at Pfizer allows her to collaborate with leading experts in the field and contribute to groundbreaking innovations in medicine.
Collaborations
Dinah has worked alongside notable colleagues, including Stephen Charles Phillips and John Ridden. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Dinah Parums is a pioneering inventor whose work in targeted therapeutics is making a difference in the medical field. Her contributions, particularly in relation to scarring and fibrosis, highlight the importance of innovation in improving healthcare solutions.